세계의 경피 패치 시장 규모, 점유율, 동향, 예측 : 유형, 유통 채널, 용도, 지역별(2025-2033년)
Transdermal Skin Patches Market Size, Share, Trends and Forecast by Type, Distribution Channel, Application, and Region, 2025-2033
상품코드:1722864
리서치사:IMARC
발행일:2025년 05월
페이지 정보:영문 147 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
경피 패치 세계 시장 규모는 2024년 82억 1,000만 달러에 달했습니다. 향후 IMARC Group은 2033년까지 이 시장이 2025-2033년 3.69%의 연평균 복합 성장률(CAGR)을 나타내고, 115억 6,000만 달러에 달할 것으로 예측했습니다. 현재 북미가 시장을 독점하고 있으며, 2024년에는 35.5%의 높은 시장 점유율을 차지했습니다. 이 시장이 성장하고 있는 이유는 혁신적인 경피적 기술을 뒷받침하는 첨단 의료 인프라가 있기 때문입니다. 만성질환의 높은 유병률로 인해 효과적이고 비침습적인 치료 옵션에 대한 수요가 지속적으로 증가하고 있습니다. 또한, 제약회사의 강력한 입지와 유리한 규제 프레임워크는 제품 개발 및 규제 승인을 촉진하여 경피 패치 세계 시장 점유율에서 이 지역의 중요성을 확고히 하고 있습니다.
경피 패치는 비침습적이고 사용하기 쉬운 약물 전달 방식으로, 일정량의 치료제를 미리 정해진 시간 동안 혈류에 투여하는 것을 말합니다. 이러한 약물은 백킹, 약물, 멤브레인, 접착제, 라이너, 화학적 강화제 또는 침투제, 물리적 보조제, 이온영동과 같은 약한 전류로 구성됩니다. 이들은 피부의 특성과 패치 디자인에 따라 일정한 확산 속도를 제공합니다. 현재 화장품, 외용제, 경피흡수형 제제로 전 세계적으로 널리 사용되고 있습니다.
경피 패치 시장 동향 :
경피 패치는 심장병, 호르몬 장애, 편두통, 파킨슨병, 알츠하이머병, 뇌졸중, 인간면역결핍바이러스(HIV), 골다공증, 하지불안증후군 등의 치료에 효과적입니다. 따라서 이러한 질병을 앓고 있는 인구의 비율이 크게 증가하고 있는 것은 시장 성장을 가속하는 중요한 요인 중 하나입니다. 또한, 이러한 패치는 의약품을 섭취하는 전통적인 경구 경로를 피하고 정맥 또는 비경구 요법으로 인한 불편을 줄이고 위장 독성, 메스꺼움 및 구토를 예방하는 데 도움이 됩니다. 또한, 투여가 용이하기 때문에 만성 통증 및 금연 치료를 위한 장기 치료 중 환자의 순응도를 향상시키기 위해 경피 패치의 인기가 높아지고 있습니다. 이와는 별도로, 저렴한 비용으로 더 나은 치료법에 대한 수요 증가와 다양한 약물 계열에 대한 임상시험의 수가 크게 증가하면서 시장에 긍정적인 영향을 미치고 있습니다. 또한, 압력에 민감한 접착제 및 침투 촉진제의 도입은 제품의 확산을 촉진하고 약물 보유 능력을 강화하여 시장 기업에게 유리한 기회를 제공하고 향후 몇 년 동안 전 세계적으로 경피 패치의 적용이 확대될 것으로 예측됩니다.
The global transdermal skin patches market size was valued at USD 8.21 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 11.56 Billion by 2033, exhibiting a CAGR of 3.69% during 2025-2033. North America currently dominates the market, holding a significant market share of 35.5% in 2024. The market is experiencing growth because of advanced healthcare infrastructure supporting innovative transdermal technologies. High prevalence of chronic conditions ensures sustained demand for effective, non-invasive treatment options. Besides this, strong presence of pharmaceutical companies and favorable regulatory frameworks drive product development and regulatory approvals, solidifying the region's significance in the global transdermal skin patches market share.
Transdermal skin patches refer to a non-invasive and easy to use drug delivery method of administering constant and consistent therapeutic dosages into the bloodstream over a predetermined time. They consist of backings, drugs, membranes, adhesives, liners, chemical enhancers and permeators, physical aids, and low electrical current like iontophoresis. They provide a consistent diffusion rate, depending on the characteristics of the skin and the design of the patch. They are nowadays widely used as cosmetic, topical, and transdermal delivery systems around the world.
Transdermal Skin Patches Market Trends:
Transdermal skin patches are effective for treating cardiac and hormonal disorders, migraine, Parkinson's disease, Alzheimer's, stroke, human immunodeficiency virus (HIV), osteoporosis, and restless leg syndrome. Thus, a significant increase in the percentage of the population suffering from these ailments represents one of the key factors impelling the market growth. Moreover, these patches help avoid the traditional oral route for ingesting medicines, lower the inconvenience caused due to intravenous or parenteral therapies, and prevent gastrointestinal toxicity, nausea, and vomiting. Furthermore, due to the ease of administration, transdermal skin patches are gaining traction to improve the compliance of the patient during prolonged treatments for chronic pains and in smoking cessation therapy. Apart from this, the escalating demand for better therapeutics at affordable costs, coupled with a significant rise in the number of clinical trials of different drugs classes, is positively influencing the market. Furthermore, the introduction of pressure-sensitive adhesives and permeation enhancers, which lead to increased product diffusion and enhanced drug retention ability, is anticipated to provide lucrative opportunities to market players and expand the application of transdermal skin patches across the globe in the coming years.
Key Market Segmentation:
Breakup by Type:
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Matrix
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Stores
Breakup by Application:
Pain Relief
Smoking Reduction and Cessation Aid
Overactive Bladder
Hormonal Therapy
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report
1.How big is the transdermal skin patches market?
2.What is the future outlook of transdermal skin patches market?
3.What are the key factors driving the transdermal skin patches market?
4.Which region accounts for the largest transdermal skin patches market share?
5.Which are the leading companies in the global transdermal skin patches market?
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Transdermal Skin Patches Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Single-layer Drug-in-Adhesive
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Multi-layer Drug-in-Adhesive
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Matrix
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Distribution Channel
7.1 Hospital Pharmacies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacies
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Online Stores
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Pain Relief
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Smoking Reduction and Cessation Aid
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Overactive Bladder
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Hormonal Therapy
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 3M Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AdhexPharma
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 LTS Lohmann Therapie-Systeme AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Luye Pharma Group
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Medherant Limited
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Nitto Denko Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Prosolus Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Samyang Holdings Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Tapemark
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
